Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
Freedland SJ, Seligson DB, Liu AY, Pantuck AJ, Paik SH, Horvath S, Wieder JA, Zisman A, Nguyen D, Tso CL, Palotie AV, Belldegrun AS.
Freedland SJ, et al. Among authors: palotie av.
Prostate. 2003 Apr 1;55(1):71-80. doi: 10.1002/pros.10202.
Prostate. 2003.
PMID: 12640663